Form4insider filings, from the source

SEC Form 4 · accession 0001628280-17-012316

Jazz Pharmaceuticals plc · JAZZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Russell J. Cox
Officer — EVP & COO
Period of report
Dec 11, 2017
Accepted (ET)
Dec 13, 2017 · 5:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1Dec 11, 2017M44,200$8.23A96,263D
Ordinary SharesDec 11, 2017M4,867$46.83A101,130D
Ordinary SharesDec 11, 2017M1,691$59.13A102,821D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Incentive Stock Option (right to buy)F2$8.23Dec 11, 2017M44,200D—Aug 24, 2020Ordinary Shares44,2000D
Incentive Stock Option (right to buy)F3$46.83Dec 11, 2017M4,867D—Aug 8, 2022Ordinary Shares4,8670D
Incentive Stock Option (right to buy)F4$59.13Dec 11, 2017M1,691D—Mar 4, 2023Ordinary Shares1,6910D

Explanation of responses